Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Irish Pharmaceutical Healthcare Association .
Filed returns
182
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Treatment Abroad Scheme and Cell Gene Therapies (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | EU Pharmaceutical Strategy (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Access to new medicines (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Extension of framework agreement on medicines. (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2020 | Irish Pharmaceutical Healthcare Association | Health | Readiness of Ireland to produce and provide cell and gene therapies (Matters involving public funds) | 1 | On lobbying.ie |
| Sep–Dec 2020 | Irish Pharmaceutical Healthcare Association | Health | Potential for new IPHA Medicines Supply Agreement (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2020 | Irish Pharmaceutical Healthcare Association | Health | Government policy on access to new medicines (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2020 | Irish Pharmaceutical Healthcare Association | Health | Establishment of National Medicines Agency (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2020 | Irish Pharmaceutical Healthcare Association | Health | Interaction between DPER and DoH/HSE on funding for new medicines (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2020 | Irish Pharmaceutical Healthcare Association | Health | New Framework Agreement between the State and IPHA on supply of medicines (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2020 | Irish Pharmaceutical Healthcare Association | Health | Medicines Policy and Programme for Government (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2020 | Irish Pharmaceutical Healthcare Association | Health | Importance of a definitive and focused medicines policy, especially regarding access, in the Programme for Government (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2020 | Irish Pharmaceutical Healthcare Association | Health | Directive on Best Value Biologics (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2020 | Irish Pharmaceutical Healthcare Association | Health | Importance of medicines policy in General Election dialogue (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2020 | Irish Pharmaceutical Healthcare Association | Health | Operation of current Medicines Supply Agreement and planning for successor agreement (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2019 | Irish Pharmaceutical Healthcare Association | Health | New medicines Supply Agreement with State (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Irish Pharmaceutical Healthcare Association | Health | Report commissioned by Department of Health from Mazars on drug reimbursement system (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Irish Pharmaceutical Healthcare Association | Health | State spend on medicines in hospitals 2015 to 2018 (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Irish Pharmaceutical Healthcare Association | Health | New Supply Agreement and State vaccines group (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | IPHA approach to new supply agreement and current policy provisions (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | PwC report for EFPIA on value of pharmaceutical industry (Public policy or programme) | 11 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | Health Committee hearings on medicines (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | IPHA Manifesto for Better Health (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | Government policy on access to new medicines (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | Prescriber incentives for biosimilars (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | World Health Assembly - Italian proposal on pharmacuticals (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | Official policy on biologics (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | Policy Forum for Ireland’s BioPharma Future and ‘BioPharma Ambition 2020 (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | Manifesto of the European Federation of Pharmaceutical Industries and Associations (EFPIA) for the European elections (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | EU draft legislation to alter IP protections for pharmaceutical industry (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | To highlight importance of continuity of supply of medicines in Europe post Brexit (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | IPHA policy document "Manifesto for Better Health" (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | Proposed dialogue between industry and State on an improved reimbursement system for medicines (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | Originator pharmaceutical industry's preparations for Brexit (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Impact of Brexit on medicines supply (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Private members bill to amend Health Act and introduce a separate reimbursement process for orphan drugs (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Medicine pricing (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | IPHA 'Manifesto for Better Health' (Public policy or programme) | 25 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Irish Government Economic and Evaluation Service (IGEES) policy forum on drug costs (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Inclusion of medicine regulation in Brexit withdrawal agreement (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | IPHA member companies preparation for Brexit (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Inclusion of IPHA position on access to innovative medicines in discussions on renewal of Confidence and Supply Agreement (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | EU Commission proposals to introduce an SPC waiver on pharmaceutical products (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Liaison with Deputy Dara Calleary regarding the reimbursement status of Spinraza (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | To advise the Fianna Fail Spokesperson on Health and members of the joint Oireachtas Committee on Health of IPHA concerns on a private members bill to amend the Health (Pricing and Supply of Medical Goods) Act 2013 (Public policy or programme) | 11 | On lobbying.ie |
| May–Aug 2018 | Irish Pharmaceutical Healthcare Association | Health | To arrange briefing meetings with Government Special Advisors (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2018 | Irish Pharmaceutical Healthcare Association | Health | EU legislative proposal to introduce an SPC waiver on pharmaceutical products (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2018 | Irish Pharmaceutical Healthcare Association | Health | Briefing of Fianna Fáil Deputy Leader and Director of Policy, Dara Calleary, TD (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2018 | Irish Pharmaceutical Healthcare Association | Health | Briefing of Fianna Fáil Spokesperson on Health, Stephen Donnelly TD (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2018 | Irish Pharmaceutical Healthcare Association | Health | IPHA political series with Health spokespersons (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 182 | 100.0% |